NCT06351943 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Audige L, Bhandari M, Hanson B, Kellam J
A concept for the validation of fracture classifications. J Orthop Trauma. 2005 Jul;19(6):401-6. doi: 10.1097/01.bot.0000155310.04886.37.
Langerhuizen DWG, Janssen SJ, Mallee WH, van den Bekerom MPJ, Ring D, Kerkhoffs GMMJ, Jaarsma RL, Doornberg JN
What Are the Applications and Limitations of Artificial Intelligence for Fracture Detection and Classification in Orthopaedic Trauma Imaging? A
Meinberg EG, Agel J, Roberts CS, Karam MD, Kellam JF
Fracture and Dislocation Classification Compendium-2018. J Orthop Trauma. 2018 Jan;32 Suppl 1:S1-S170. doi: 10.1097/BOT.0000000000001063. No abstract available.
Tanzi L, Vezzetti E, Moreno R, Aprato A, Audisio A, Masse A
Hierarchical fracture classification of proximal femur X-Ray images using a multistage Deep Learning approach. Eur J Radiol. 2020 Dec;133:109373. doi: 10.1016/j.ejrad.2020.109373. Epub 2020 Oct

Validation of the Fracture Classification Accuracy (Ground Truth) of Anteroposterior X-ray of the Proximal Femur According to the Arbeitsgemeinschaft für Osteosynthesefragen/Orthopedic Trauma Association Classification Done by a Single Center: A Pilot Validation Study

Details for clinical trial NCT06351943

Clinical trial NCT06351943 - References